dartisla odt
Pharmaranks rates Dartisla ODT 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Dartisla ODT (Glycopyrrolate) is an anticholinergic used to treat Hyperhidrosis, Drug-Induced Abnormalities, Peptic Ulcer, Respiratory Tract Diseases.
Glycopyrrolate · by Edenbridge Pharms
Available as a generic: Glycopyrrolate
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Glycopyrrolate
- Drug class
- Anticholinergic
- Form
- Tablet, orally disintegrating
- Strength
- Glycopyrrolate 0.85MG · Glycopyrrolate 1.7MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- hyperhidrosis, drug-induced abnormalities, peptic ulcer
- Manufacturer
- Edenbridge Pharms
- What the pharmacy pays
- ~$0.20 per ml — not your price
- FDA application
- NDA215019
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Muscarinic Antagonists - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Dartisla ODT ranks — best-rated anticholinergic for:
Dosage forms
Tablet, orally disintegrating
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Dartisla ODT treat?
- Dartisla ODT (Glycopyrrolate) may be used to treat hyperhidrosis, drug-induced abnormalities, peptic ulcer, respiratory tract diseases, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Dartisla ODT work?
- Dartisla ODT is a anticholinergic. Anticholinergic drugs block acetylcholine, the chemical messenger of the body's "rest and digest" nervous system, by occupying its muscarinic receptors. This eases muscle spasms, dries up secretions, relaxes the bladder and airways, and speeds the heart, depending on the tissue.
- How is Dartisla ODT rated?
- pharmaranks gives Dartisla ODT a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Dartisla ODT cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $0.20 per ml, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Dartisla ODT?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Dartisla ODT. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Dartisla ODT?
- Dartisla ODT is marketed by Edenbridge Pharms. You can see Edenbridge Pharms's full profile, rating, and other products on pharmaranks.
- Is Dartisla ODT a brand-name or generic drug?
- Dartisla ODT is a brand-name product with the active ingredient Glycopyrrolate. Lower-cost generic equivalents containing Glycopyrrolate are available — ask your pharmacist.
- Is Dartisla ODT available over the counter?
- No. Dartisla ODT is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Dartisla ODT come in?
- Dartisla ODT is currently marketed as tablet, orally disintegrating, per the FDA's National Drug Code Directory.
- What class of drug is Dartisla ODT?
- Dartisla ODT is classified as anticholinergic, cholinergic muscarinic antagonist, per the FDA's Established Pharmacologic Class.
- Is Dartisla ODT FDA-registered?
- Dartisla ODT is on record with the U.S. FDA under application number NDA215019. You can verify this on its official FDA label.
- Has Dartisla ODT been recalled by the FDA?
- Dartisla ODT has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Dartisla ODT safe?
- There's no single safe-or-not verdict. pharmaranks gives Dartisla ODT a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about GLYCOPYRROLATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 9,620 reports naming GLYCOPYRROLATE — the active ingredient in Dartisla ODT, and the FDA flagged 89% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- dyspnoea1,584 reports
- asthma1,018 reports
- cough945 reports
- pneumonia865 reports
- wheezing813 reports
- malaise585 reports
- chronic obstructive pulmonary disease566 reports
- fatigue549 reports
Read these as a signal, not a rate. A report does not mean GLYCOPYRROLATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
atrovent hfa
Ipratropium Bromide
dicyclomine hydrochloride
Dicyclomine Hydrochloride
spiriva respimat
Tiotropium Bromide
tudorza pressair
Aclidinium Bromide
spiriva
Tiotropium Bromide
atropine sulfate
Atropine Sulfate
Compare Dartisla ODT head-to-head
More anticholinergic drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
dartisla odt
70/100